DexCom authorized spending up to $1 billion to buy back its shares by the end of 2027. This could return money to shareholders, but the company has not said how many shares it will buy.
The plan gives DexCom a way to return money to shareholders and could reduce the number of shares. But it only allows purchases up to a limit; it does not say how many shares DexCom will actually buy.
Follow DexCom (DXCM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for DXCM